首页
400-620-6333
应用
选项
-
Vilobelimab (anti-Complement C5)关联靶标: C5简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 非洲绿猴(African green monkey) 亚型: Human IgG4SP宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2250440-41-4
-
Diridavumab (anti-HA)简短描述: Purity≥95% Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level≤1.0EU/mg; Human IgG1-REM; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 甲型流感(Influenza A) 亚型: Human IgG1-REM宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1393659-46-5
-
Navivumab (anti-HA)简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 甲型流感(Influenza A) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1443004-16-7
